Skip to main content

Another stroke update! (Last one! For now..)

Ischemic stroke and Transient Ischemic Attack have been a vigorously studied subject, particularly in the past few years. With numerous updates and recommendations, we will provide an updated guide for Emergency Physicians in regards to ischemic stroke and TIA management and workup.

Endovascular therapy for Ischemic Stroke:

  • In 2013, three high quality studies published in NEJM failed to show a benefit for endovascular therapy, compared to standard treatment [1-3]. 
  • Within two years, however, there was a significant paradigm shift to alter this theory, based on five high quality studies published in NEJM, showing a benefit for endovascular therapy in ischemic stroke [4-8]. 
  • The newer studies had some fundamental differences in comparison to the earlier negative trials [9]:
    • Strict patient selection: Most studies used stroke onset < 6 hours, with the ESCAPE trial having the longest inclusion time with stroke onset <12 hours [4]. 
    • Improved imaging selection: Demonstration of a large proximal clot in the anterior circulation with an salvageable ischemic penumbra [10,11].
    • New Technologies: Development of mechanical thrombectomy with new generation retrievable stents instead of intra-arterial tPA. 
Each of these 2015 studies were fairly similar, aside from a few important differences:

  • The primary outcome of each study was Modified Rankin Score at 90 days, and all studies demonstrated that the endovascular therapy group was associated with functional independence (mRS of 0-2) at 90 days compared to standard therapy [12]. 
    • NNT from all of these positive studies ranged from 4-8. 
  • The ESCAPE trial additionally demonstrated an mortality benefit at 90 days, with an NNT of 11 [4]. 
  • Across all studies there was no statistical difference in events of symptomatic intracranial hemorrhage at 90 days. 
  • Of note, although the ESCAPE trial randomized patients up to 12 hours after stroke onset, only a small number of patients were actually randomized after 6 hours, and the results were not statistically significant (although, the direction of effect favoured endovascular therapy) [4]. 
  • All of the trials were stopped early, with the exception of MR CLEAN (as that was the first trial released, demonstrating the initial benefit of endovascular therapy). 

Limitations and future directions:

  • Endovascular therapy has been demonstrated to have a clear benefit in a SPECIFIC patient population.
    • Benefit has not yet been demonstrated in an expanded patient population. 
    • Smaller occlusions more amenable to IV tPA, and larger occlusions more amenable to thrombectomy. 
  • Upper time limit for this benefit is still unknown
    • Most studies used <6 hours from stroke onset as their inclusion
    • ESCAPE randomized patients up to 12 hours, but those included after 6 hours did not yield an statistical benefit. 
  • Future directions will likely include a shift from "last time seen well" towards "imaging completed" to determine the time course for intervention. 

Bottom lines:

Imaging in TIA

  • It is well known that the risk of stroke is highest immediately following an TIA, and that intervening at this point can improve long term outcomes [13-16]. 
  • Classically, clinical prediction scores such as ABCD2 have been used for risk stratification but have not performed well [17]. 

What about imaging findings contributing to risk evaluation?

CT Head:
  • A study published in Stroke last year investigated the link between imaging findings of acute ischemia on non-contrast CT head in patients presenting with TIA, and subsequent risk of recurrent stroke [18]. 
    • The study included over 2000 TIA patients presenting to Canadian ED's, and assessed the head CT for acute/chronic ischemia or microangiopathy, with stroke at 90 days representing their primary outcome.
    • The authors found that as the "ischemic load" increased, the risk of recurrent stroke increased as well (OR of 3-8), with a large part of that risk occurring in the first 48 hours after presentation. 
    • This suggests that ischemic changes on a non-contrast CT head greatly increase the risk of subsequent stroke in TIA patients
Vascular imaging:
  • Historically, vascular imaging in the setting of TIA was mainly used to evaluate for carotid stenosis, following the NASCET study in 1998, which demonstrated an large benefit for carotid endarterectomy in symptomatic carotid stenosis ≥ 50% [19]. 
  • With increasing availability of CT-A (especially after hours), this became another viable alternative to carotid dopplers, with the caveat that this will increase visualization of potentially asymptomatic lesions. 
  • To better help determine which patients would benefit from vascular imaging, the CATCH study published in Stroke in 2012 demonstrated that CT-A findings could predict recurrent stroke in TIA and minor stroke patients [20]. 
    • Patients presenting with high risk TIA features (focal weakness or speech disturbance) or minor ischemic stroke (NIHSS <3) underwent CT and CT-A, and were followed to 90 days to determine of recurrent stroke occurred. 
    • CT/CT-A was considered positive if any of the following were seen:
      • Acute ischemic change seen on CT.
      • Intracranial or extracranial vessel occlusion
      • Stenosis ≥ 50% ipsilateral to the clinically relevant ischemic brain tissue. 
    • The study found that abnormal CT/CT-A imaging had a significantly higher risk of recurrent stroke.  Of note, intracranial stenosis or occlusion was identified to be as high risk as extracranial stenosis or occlusion. 

Bottom Line: 

  • Higher risk patients should receive an CT-A prior to leaving the Emergency Department. 
    • High risk patients are those with a) motor symptoms, or b) speech symptoms
  • Patients presenting with TIA require an neurology consultation in the department if they have one of the following features:
    • Acute stroke on CT Head
    • Free floating thrombus
    • Carotid artery stenosis ≥ 50% (in conjunction with vascular surgery). 
    • Of note: these indications for neurology referral are predicated by imaging findings, rather than clinical findings.

Dr. Simeon Mitchell is a 3rd year Emergency Medicine resident at the University of Ottawa, with a special interest in Emergency Medical Services. 

Edited by Dr. Shahbaz Syed, PGY-4 Emergency Medicine, University of Ottawa.

  1. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R. Endovascular Treatment for Acute Ischemic Stroke. New. 2013;268:904-913. doi:10.1056/NEJMoa1213701
  2. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914-923. doi:10.1056/NEJMoa1212793
  3. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903. doi:10.1056/NEJMoa1214300
  4. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030. doi:10.1056/NEJMoa1414905
  5. Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med. 2015;372(11):1009-1018
  6. Berkhemer O, Fransen P, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. New Engl J Med. 2014;372(1):11-20. doi:10.1056/NEJMoa1411587
  7.  Saver JL, Goyal M, Bonafe A, et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med. 2015;372(24):2285-2295. doi:10.1056/NEJMoa1415061
  8. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J Med. 2015;372(24):1-11. doi:10.1056/NEJMoa1503780
  9. Furlan AJ. edi t or i a l s Endovascular Therapy for Stroke — It ’ s about Time. 2015:2347-2349.
  10. Pexman JHW, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am J Neuroradiol. 2001;22(8):1534-1542
  11. Menon BK, D’Esterre CD, Qazi E, et al. Multi-phase CTA: A new tool for the imaging triage of patients with acute ischemic stroke. Int J Stroke. 2015;10(2):307-308
  12. Badhiwala JH, Nassiri F, Alhazzani W, et al. Endovascular Thrombectomy for Acute Ischemic Stroke. Jama. 2015;314(17):1832. doi:10.1001/jama.2015.13767
  13. othwell PM, Warlow CP. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology. 2005;64(5):817-820. doi:10.1212/01.WNL.0000152985.32732.EE
  14. Lisabeth LD, Ireland JK, Risser JMH, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004;35(8):1842-1846. doi:10.1161/01.STR.0000134416.89389.9d
  15. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370(9596):1432-1442. doi:10.1016/S0140-6736(07)61448-2
  16. Lavallée PC, Meseguer E, Abboud H, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6(11):953-960. doi:10.1016/S1474-4422(07)70248-X.
  17. Kamal N, Hill MD, Blacquiere DPV, et al. Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments: Figure. Stroke. 2015;46(10):2987-2990. doi:10.1161/STROKEAHA.115.010454
  18. Wasserman JK, Perry JJ, Sivilotti ML a, et al. Computed Tomography Identifies Patients at High Risk for Stroke After Transient Ischemic Attack/Nondisabling Stroke: Prospective, Multicenter Cohort Study. Stroke. 2014:1-7. doi:10.1161/STROKEAHA.114.006768
  19. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. N. 1998:1415-1425
  20. Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD. CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: Results of the prospective CATCH study. Stroke. 2012;43(4):1013-1017. doi:10.1161/STROKEAHA.111.637421


Popular posts from this blog

Tips for Success in your Emergency Medicine Rotation

Our wonderful medical students are preparing to start their first clinical rotations. With this in mind here are some of the top tips for success in your EM rotation
1)Be On Time – show up to your shifts on time, better yet 5 minutes early.That first impression is immensely important.
2)Introduce yourself to the team - “Hi my name is John Doe, I am the medical student on shift today” introduce yourself to the attending, residents, nurses, etc.You will be called on a lot more to help when there is something interesting going on if they know your name.
3)Be goal-oriented – have a goal for each shift, whether it’s a procedure or a type of presentation to see.
4)Don’t just stand there, do something – whenever there is a trauma or code, come to the bedside.Get gowned up for traumas and pay attention.Help with things that are within your scope of practice: chest compressions, moving patient, cardioversion
5)Don’t just stand there, do nothing – there are times in medicine when the best thing to d…

2014 Canadian Guidelines for AF Management: Part 1: Introduction and CCS “CHADS-65” Algorithm

by Ian Stiell MD @EMO_Daddy

In this and subsequent postings we will discuss the latest recommendations for ED management of atrial fibrillation (AF) as presented in the newly published 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. The Guidelines PDF can be downloaded from the CCS website at 2014 Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
The 2014 Focused Update uses the GRADE system of evidence evaluation as was the case in the comprehensive 2010 AF Guidelines and the 2012 Update. The CCS AF Guidelines Panel is comprised of Canadian cardiologists plus physicians from internal medicine, family medicine, neurology, and emergency medicine. This 2014 Update provides evidence review and recommendations for 8 aspects of AF care, including ED Management (written by myself and Dr. Laurent Macle of the Montreal Heart Institute). The 2014 Update focuses on advances in oral anticoagulant (O…

You CAN reverse that! Reversal of NOAC's and more..

We have seen a large surge of the utilization of New Oral Anticoagulants (NOAC's) in the past few years, as such, it has been a novel challenge when these patients present to the Emergency Department (ED) with life threatening bleeding. Dr. Michael Ho looks to discuss treatment options, and future options in these patients. 
NOACs vs WarfarinDabigatran, Rivaroxaban and Apixaban have seen a dramatic increase in use since their approval in Canada. Dabigatran is a direct thrombin (Factor II) inhibitor, while the latter two are direct Xa inhibitors. These drugs are collectively referred to as novel oral anticoagulants (NOACs). They have also been called direct, or target-specific oral anticoagulants (DOACs or TSOACs) [1]. 
The NOACs have many practical advantages over warfarin: Rapid onset of actionShorter half-lifeLess food and drug interferencePredictable pharmacokineticsEase of use and no requirement for monitoringThe downsides to NOACs are the higher cost to the patient, the inabilit…